PT70130A - N2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof - Google Patents

N2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof

Info

Publication number
PT70130A
PT70130A PT70130A PT7013079A PT70130A PT 70130 A PT70130 A PT 70130A PT 70130 A PT70130 A PT 70130A PT 7013079 A PT7013079 A PT 7013079A PT 70130 A PT70130 A PT 70130A
Authority
PT
Portugal
Prior art keywords
argininamides
arylsulfonyl
pharmaceutically acceptable
acceptable salts
salts
Prior art date
Application number
PT70130A
Other languages
English (en)
Original Assignee
Mitsubishi Chem Ind
Okamoto Shosuke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/938,711 external-priority patent/US4201863A/en
Priority claimed from US06/041,419 external-priority patent/US4258192A/en
Application filed by Mitsubishi Chem Ind, Okamoto Shosuke filed Critical Mitsubishi Chem Ind
Publication of PT70130A publication Critical patent/PT70130A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
PT70130A 1978-08-31 1979-08-29 N2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof PT70130A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/938,711 US4201863A (en) 1974-11-08 1978-08-31 N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US06/041,419 US4258192A (en) 1977-12-16 1979-05-22 N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof

Publications (1)

Publication Number Publication Date
PT70130A true PT70130A (en) 1979-09-01

Family

ID=26718116

Family Applications (1)

Application Number Title Priority Date Filing Date
PT70130A PT70130A (en) 1978-08-31 1979-08-29 N2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof

Country Status (17)

Country Link
EP (1) EP0008746B1 (pt)
AU (1) AU520342B2 (pt)
CA (1) CA1135698A (pt)
CS (1) CS228119B2 (pt)
DD (1) DD146600A5 (pt)
DE (1) DE2963539D1 (pt)
DK (1) DK152495C (pt)
ES (1) ES483767A1 (pt)
FI (1) FI66183C (pt)
GR (1) GR64905B (pt)
HU (1) HU179734B (pt)
IE (1) IE48623B1 (pt)
NO (1) NO151588C (pt)
NZ (1) NZ191434A (pt)
PH (1) PH15662A (pt)
PL (1) PL121663B1 (pt)
PT (1) PT70130A (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5993054A (ja) * 1982-11-18 1984-05-29 Asahi Chem Ind Co Ltd イソキノリンスルホン酸アミド誘導体
JPS61112018A (ja) * 1984-11-06 1986-05-30 Mitsubishi Chem Ind Ltd 線溶増強剤
FR2689130B1 (fr) 1992-03-30 1994-05-27 Synthelabo Derives de 1-[2 (arylsulfonylamino)ethyl-1-oxo] piperidine, leur preparation et leur application en therapeutique.
US5585498A (en) * 1992-03-30 1996-12-17 Synthelabo Imidazole derivatives useful as synthetic intermediates
GB9209032D0 (en) * 1992-04-25 1992-06-10 Ciba Geigy Ag New peptide derivatives
JPH06219948A (ja) * 1993-01-25 1994-08-09 Mitsubishi Kasei Corp 抗トロンビン剤及びその製造方法
JPH06219949A (ja) * 1993-01-25 1994-08-09 Mitsubishi Kasei Corp 抗トロンビン剤及びその製造方法
FR2702220B1 (fr) * 1993-03-03 1995-05-12 Synthelabo Dédoublement enzymatique de dérivés de 4-alkyl-2-pipéridine-carboxylate et utilisation des composés obtenus, comme intermédiaires de synthèse.
ATE177635T1 (de) * 1993-04-22 1999-04-15 Senju Pharma Co Wässrige arzneizubereitungen enthaltend argatroban und cyclodextrin oder coffein
FR2710067B1 (fr) * 1993-09-14 1995-10-20 Synthelabo Procédé de préparation de 2-amino-5-(1H-imidazol-4-yl)-1-oxopentylpipéridine.
FR2710066B1 (fr) * 1993-09-14 1995-10-20 Synthelabo Dérivés de 1-[2-amino-5-[1-(triphénylméthyl-1H-imidazol-4-yl]-1-oxopentyl]piperidine, leur préparation et leur utilisation comme intermédiaires de synthèse.
FR2710061B1 (fr) * 1993-09-14 1995-12-29 Synthelabo Acides et chlorures d'acides 1,2,3, 4-tétrahydroquinoléine-8-sulfoniques, et leur utilisation comme intermédiaires de synthèse.
FR2715566B1 (fr) * 1994-02-03 1996-03-08 Synthelabo Solutions aqueuses concentrées d'argatroban.
FR2718439B3 (fr) * 1994-04-12 1996-02-09 Synthelabo Dérivés de l'acide pipécolique, leur préparation et leur utilisation comme intermédiaires de synthèse.
DE4424828A1 (de) * 1994-07-14 1996-01-18 Thomae Gmbh Dr K Neue substituierte Arylsulfonamide, ihre Herstellung und ihre Verwendung als Arzneimittel
GB9505538D0 (en) * 1995-03-18 1995-05-03 Ciba Geigy Ag New compounds
GB9508622D0 (en) * 1995-04-28 1995-06-14 Pfizer Ltd Therapeutic agants
FR2735469B1 (fr) * 1995-06-13 1997-07-11 Synthelabo N2-(arylsulfonyl)-l-arginylpiperidin-2-carboxylates, leur preparation et leur application en therapeutique
FR2747676B1 (fr) * 1996-04-22 1998-06-05 Synthelabo Derives de [1-oxo-2-(sulfonylamino)ethyl] piperidine, leur preparation et leur application en therapeutique
US5840733A (en) 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US5925760A (en) * 1996-08-07 1999-07-20 Mitsubishi Chemical Corporation Method for preparing N2 -arylsulfonyl-L-argininamides
FR2804682B1 (fr) * 2000-02-09 2002-05-03 Rhodia Chimie Sa Procede de preparation diastereoselective de piperidines fonctionnalisees en positions 2 et 4 utilisables comme intermediaires de synthese
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および／または線溶系酵素阻害剤との組み合わせからなる医薬
CN100427480C (zh) * 2006-11-10 2008-10-22 天津市炜杰科技有限公司 阿加曲班水合物的制备方法
US7915290B2 (en) 2008-02-29 2011-03-29 Baxter International Inc. Argatroban formulations and methods for making and using same
CN101914133B (zh) * 2008-03-07 2013-01-30 天津市炜杰科技有限公司 一种21(s)阿加曲班的定向合成方法
ITPD20080106A1 (it) 2008-04-07 2009-10-08 Lundbeck Pharmaceuticals Italy Spa Metodo di preparazione di argatroban monoidrato
EP2305646A1 (en) 2009-10-02 2011-04-06 Enantia, S.L. A process for the preparation of trans-(2R)-4-substituted-pipecolic acids and esters thereof, and intermediate compounds used therein
ITMI20110545A1 (it) 2011-04-04 2012-10-05 Lundbeck Pharmaceuticals Italy S P A Metodo per la preparazione di intermedi di processo per la sintesi di argatroban monoidrato
CN103570803B (zh) * 2012-08-30 2015-06-03 上海科胜药物研发有限公司 一种阿加曲班中间体的制备方法
CN104672132B (zh) * 2013-11-28 2017-06-16 四川科瑞德制药股份有限公司 阿加曲班中间体的合成方法
CN104098647B (zh) * 2014-06-24 2017-12-08 安徽省逸欣铭医药科技有限公司 阿加曲班类似物及其制备方法和医药用途
CN106928199B (zh) * 2017-05-08 2020-06-09 安徽医学高等专科学校 一种嘧啶化合物的晶型c的制备方法和用途
CN109912570A (zh) * 2019-04-04 2019-06-21 天津药物研究院药业有限责任公司 一种阿加曲班中间体酰胺化物的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1131621A (en) * 1977-01-19 1982-09-14 Shosuke Okamoto N.sup.2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof

Also Published As

Publication number Publication date
IE48623B1 (en) 1985-03-20
PH15662A (en) 1983-03-11
GR64905B (en) 1980-06-07
FI792637A (fi) 1980-03-01
DD146600A5 (de) 1981-02-18
FI66183C (fi) 1984-09-10
AU5048679A (en) 1980-03-06
NO151588B (no) 1985-01-21
ES483767A1 (es) 1980-04-16
DK152495B (da) 1988-03-07
NZ191434A (en) 1984-07-06
IE791565L (en) 1980-02-29
EP0008746B1 (en) 1982-08-11
DK364579A (da) 1980-03-01
CS228119B2 (en) 1984-05-14
EP0008746A1 (en) 1980-03-19
DE2963539D1 (en) 1982-10-07
NO151588C (no) 1985-05-08
PL121663B1 (en) 1982-05-31
CA1135698A (en) 1982-11-16
AU520342B2 (en) 1982-01-28
PL218008A1 (pt) 1980-05-05
FI66183B (fi) 1984-05-31
NO792823L (no) 1980-03-03
DK152495C (da) 1988-07-25
HU179734B (en) 1982-12-28

Similar Documents

Publication Publication Date Title
PH15662A (en) N2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
GB2085732B (en) Administration set
PH17515A (en) Pyridazinone-substituted benzimidazoles and salts thereof
AU522483B2 (en) N-alkylated aminoalcohols and their salts
ZA797054B (en) Pharmaceutically active compounds
ZA771593B (en) Hentriakontapeptides and methods for the preparation thereof
GB2034690B (en) - y - glutamyl - 3 - carboxy - 4-hydroxyanilide and salts thereof
PT65934A (en) N2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
PH12784A (en) 5-droxy-5-fluorocytidine,5-deoxy-5-fluorouridine and pharmaceutically acceptable acid addition salts thereof
GB2016010A (en) N'-phenyl-n-methylurea derivatives
GB2014984B (en) Pyrimidine-5-carboxamides the preparation and the therapeutical application thereof
JPS55133377A (en) 22benzoxepin and pharmacologically acceptable acid addition salt
PH15913A (en) N2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
ZA794581B (en) N 2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
GB1538206A (en) N2-arylsulphonyl-l-argininamides and the pharmaceutically acceptable salts thereof
GB2023599B (en) Thienopyridone and furopyridone derivatives
GB2022093B (en) Benzothalzocines and benzothiazonines
GB2016012B (en) Pharmaceutically active decahydro-isoquinoline derivatives
GB2028660B (en) Administration set
DE2966322D1 (en) Pharmaceutically active 6,9-thiaprostacyclin analogs and derivatives thereof
GB1538207A (en) N2-arylsulphonyl-l-argininamides and the pharmaceutically acceptable salts thereof
JPS53135955A (en) 111deoxyyomegaapentanolprostaglandin and like
ZA80273B (en) 4-phenylthioalkanesulfonanilides and derivatives thereof
ZA78123B (en) N2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
GB2038350B (en) Sulphamphthaleins and sulphamnaphthaleins